Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Epidemiology and risk factors; Prevention and screening; Diagnosis, staging and prognosis; Locoregional management of in situ and invasive melanoma; Systemic adjuvant treatment options; Treatment of metastatic melanoma; Emerging therapeutic options for advanced melanoma
c.1 BC Cancer Agency VAN Library | Available |
"What's the difference between targeted therapy and immunotherapy? If you're a melanoma patient, you should know. Unfortunately, most melanoma literature focuses on prevention. Patients receive a terrifying, life-threatening diagnosis and subsequently find a scarcity of information on treatment opt…
c.1 BC Cancer Agency VIC Cancer Info Ctr | On Loan, due Thursday, May 30, 2024 | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 24 February - 3 March, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |